Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma

Published:2022-09-30 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Liu Shuo¹²,Qin Zhen¹²³,Mao Yaqing¹²,Zhang Wenbo¹²,Wang Yujia¹²³,Jia Lingfei¹²³,Peng Xin¹²

Affiliation:

1. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China

2. National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing, China

3. Department of Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China

Funder

Natural Science Foundation of Beijing

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2130583

Reference63 articles.

1. Cancer statistics, 2022

2. Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes

3. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study

5. Oral cavity and oropharyngeal squamous cell carcinoma-an update

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors;Neoplasia;2024-09

2. A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression;Molecular Cancer;2024-07-09

3. The causal impact of complement C3d receptor 2 on head and neck cancer microenvironment and its implications for immunotherapy response prediction;Heliyon;2024-04

4. Targeting MYC at the intersection between cancer metabolism and oncoimmunology;Frontiers in Immunology;2024-02-08

5. Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma;Theranostics;2024